跳至主要内容
临床试验/ITMCTR2000003543
ITMCTR2000003543已完成4 期

Danlu Capsule in the treatment of mammary gland hyperplasia (imbalance of charge and discharge, stagnation and phlegm syndrome) multi-center, open, single-arm phase IV clinical trial

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 —(—)
性别
Female

入选标准

  • (1) Meet the diagnostic criteria of mammary gland hyperplasia in western medicine;
  • (2) Meet the standard of TCM syndrome differentiation of imbalance of charge and discharge,stagnation and phlegm syndrome;
  • (3) At least 18 years old;
  • (4) Informed consent, volunteer and sign the informed consent.

排除标准

  • (1) In gestation period , suckling period, serious menstrual disorder, functional uterine bleeding women;)
  • (2) Patients with breast inflammation, breast malignant tumor and simple benign tumor;
  • (3) Prophylactic and sex hormone user;
  • (4) Serious heart, liver, kidney disease or hematopoietic system disease, mental patient;
  • (5) Allergic constitution or allergic to the ingredients of the medicine used in this trial;
  • (6) Having a pregnancy plan within 3 months;
  • (7) Participated in other clinical trials within 3 months.

研究者

相似试验

Danlu Capsule in the treatment of mammary gland... | 临床试验